{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:24:09Z","timestamp":1780471449490,"version":"3.54.1"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004595","name":"Universiti Sains Malaysia","doi-asserted-by":"publisher","award":["Publication Fund"],"award-info":[{"award-number":["Publication Fund"]}],"id":[{"id":"10.13039\/501100004595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0227836","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T18:36:15Z","timestamp":1578940575000},"page":"e0227836","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Prevalence of antiphospholipid antibodies in Beh\u00e7et's disease: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5937-6473","authenticated-orcid":true,"given":"Md Asiful","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayeda Sadia","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoumik","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H. M. Safayet Ullah","family":"Prodhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahad Saif","family":"Khandker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Reshetnyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw J.","family":"Kotyla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosline","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tareq","family":"Hossan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,1,13]]},"reference":[{"key":"pone.0227836.ref001","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2133.2007.08116.x","article-title":"Clinical features and natural course of Beh\u00e7et\u2019s disease in 661 cases: a multicentre study","volume":"157","author":"E Alpsoy","year":"2007","journal-title":"Br J Dermatol"},{"key":"pone.0227836.ref002","first-page":"1078","article-title":"International study group for Behcet's disease, Criteria for Diagnosis of Behcet's Disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"pone.0227836.ref003","first-page":"1","article-title":"Pediatric Beh\u00e7et's disease-clinical aspects and current concepts","author":"M Y\u0131ld\u0131z","year":"2019","journal-title":"European journal of rheumatology"},{"key":"pone.0227836.ref004","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.autrev.2017.12.006","article-title":"Beh\u00e7et's disease: New insights into pathophysiology, clinical features and treatment options","volume":"17","author":"A Greco","year":"2018","journal-title":"Autoimmun Rev"},{"key":"pone.0227836.ref005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.01067","article-title":"Beh\u00e7et's disease: An overview of etiopathogenesis","volume":"10","author":"P Leccese","year":"2019","journal-title":"Front Immunol"},{"key":"pone.0227836.ref006","doi-asserted-by":"crossref","first-page":"e0204250","DOI":"10.1371\/journal.pone.0204250","article-title":"AIF-1 gene does not confer susceptibility to Beh\u00e7et\u2019s disease: Analysis of extended haplotypes in Sardinian population","volume":"13","author":"M.M Angioni","year":"2018","journal-title":"PLoS One"},{"key":"pone.0227836.ref007","first-page":"1","article-title":"Association of HLA-B27 and Behcet\u2019s disease: a systematic review and meta-analysis","volume":"10","author":"A Khabbazi","year":"2019","journal-title":"Auto Immun Highlights"},{"key":"pone.0227836.ref008","doi-asserted-by":"crossref","first-page":"e0199047","DOI":"10.1371\/journal.pone.0199047","article-title":"Circulating immune complexome analysis identified anti-tubulin-\u03b1-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet\u2019s Disease","volume":"13","author":"Y Cheng","year":"2018","journal-title":"PLoS One"},{"key":"pone.0227836.ref009","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/1744666X.2016.1205486","article-title":"Behcet\u2019s disease: epidemiology, clinical manifestations, and diagnosis","volume":"13","author":"F Davatchi","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"pone.0227836.ref010","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.autrev.2015.03.008","article-title":"Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases","volume":"14","author":"M Ramos-Casals","year":"2015","journal-title":"Autoimmun Rev"},{"key":"pone.0227836.ref011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/945262","article-title":"Beh\u00e7et\u2019s disease: is there geographical variation? A review far from the Silk Road","volume":"2015","author":"N.M Leonardo","year":"2015","journal-title":"Int J Rheumatol"},{"key":"pone.0227836.ref012","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/rheumatology\/kew486","article-title":"Exploring the variability in Beh\u00e7et\u2019s disease prevalence: a meta-analytical approach","volume":"57","author":"C Maldini","year":"2017","journal-title":"Rheumatology"},{"key":"pone.0227836.ref013","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0b013e3283410088","article-title":"Major vessel involvement in Beh\u00e7et's disease: an update","volume":"23","author":"K.T Calamia","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"pone.0227836.ref014","doi-asserted-by":"crossref","first-page":"e0218652","DOI":"10.1371\/journal.pone.0218652","article-title":"Increased ischemic stroke risk in patients with Beh\u00e7et\u2019s disease: A nationwide population-based cohort study","volume":"14","author":"C.-Y Wu","year":"2019","journal-title":"PLoS One"},{"key":"pone.0227836.ref015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12959-015-0047-z","article-title":"Thrombosis in vasculitis: from pathogenesis to treatment","volume":"13","author":"G Emmi","year":"2015","journal-title":"Thromb J"},{"key":"pone.0227836.ref016","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/CIRCULATIONAHA.115.017738","article-title":"Neutrophil activation promotes fibrinogen oxidation and thrombus formation in Beh\u00e7et disease","volume":"133","author":"M Becatti","year":"2016","journal-title":"Circulation"},{"key":"pone.0227836.ref017","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.autrev.2018.01.025","article-title":"Antiphospholipid antibodies in epilepsy: A systematic review and meta-analysis","volume":"17","author":"M.A Islam","year":"2018","journal-title":"Autoimmun Rev"},{"key":"pone.0227836.ref018","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.autrev.2017.03.005","article-title":"Comorbid association of antiphospholipid antibodies and migraine: A systematic review and meta-analysis","volume":"16","author":"M.A Islam","year":"2017","journal-title":"Autoimmun Rev"},{"key":"pone.0227836.ref019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2017.00250","article-title":"Presence of anticardiolipin antibodies in patients with dementia: a systematic review and meta-analysis","volume":"9","author":"M Islam","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"pone.0227836.ref020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF02231554","article-title":"Association of anti-cardiolipin antibodies with vascular thrombosis and neurological manifestation of Beh\u00e7ets disease","volume":"12","author":"A Al-Dalaan","year":"1993","journal-title":"Clin Rheumatol"},{"key":"pone.0227836.ref021","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0961203316657433","article-title":"Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity","volume":"26","author":"C Yelnik","year":"2017","journal-title":"Lupus"},{"key":"pone.0227836.ref022","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3346\/jkms.1998.13.4.400","article-title":"Anticardiolipin and anti-\u03b22-glycoprotein I antibodies in Behcet's disease","volume":"13","author":"H.J Kang","year":"1998","journal-title":"J Korean Med Sci"},{"key":"pone.0227836.ref023","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.arcmed.2005.03.019","article-title":"Lipid profile and anticardiolipin antibodies in Behcet's disease","volume":"36","author":"U Musabak","year":"2005","journal-title":"Arch Med Res"},{"key":"pone.0227836.ref024","first-page":"111","article-title":"Anticardiolipin Antibody in Patients with Beh\u00e7et's Disease with and without Vascular Thrombosis","volume":"1","author":"A Rajaee","year":"2004","journal-title":"Iran J Immunol"},{"key":"pone.0227836.ref025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/03009740252937630","article-title":"Catastrophic antiphospholipid syndrome in a patient with Beh\u00e7et's disease","volume":"31","author":"G Famularo","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"pone.0227836.ref026","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/02713689208999535","article-title":"Anticardiolipin antibodies in uveitis","volume":"11","author":"A.-M Klok","year":"1992","journal-title":"Curr Eye Res"},{"key":"pone.0227836.ref027","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting","volume":"283","author":"D.F Stroup","year":"2000","journal-title":"JAMA"},{"key":"pone.0227836.ref028","first-page":"1","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Prisma Group","year":"2009","journal-title":"PLoS Med"},{"key":"pone.0227836.ref029","article-title":"Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis","author":"M.A Islam","year":"2019","journal-title":"Autoimmun Rev"},{"key":"pone.0227836.ref030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.autrev.2016.12.005","article-title":"Calcineurin inhibitors versus cyclophosphamide for idiopathic membranous nephropathy: A systematic review and meta-analysis of 21 clinical trials","volume":"16","author":"T.T Qiu","year":"2017","journal-title":"Autoimmun Rev"},{"key":"pone.0227836.ref031","article-title":"Review manager (RevMan)[computer program] Version 5.3.5, Copenhagen: The Nordic Cochrane Centre","year":"2014","journal-title":"The Cochrane Collaboration"},{"key":"pone.0227836.ref032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"W Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"pone.0227836.ref033","doi-asserted-by":"crossref","first-page":"539","DOI":"10.21608\/ejhm.2006.17919","article-title":"Assessment of Anticardiolipin antibodies, Circulating Lupus anticoagulant, Protein C, Protein S, Antithrombin III & Activated Protein C Resistance and Their Relation to Thomboembolic and Other Clinical Manifestations in Behcet's Disease","volume":"24","author":"S.M EL-Nakeeb","year":"2006","journal-title":"Egypt J Hosp Med"},{"key":"pone.0227836.ref034","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1346-8138.1990.tb01619.x","article-title":"Anticardiolipin antibodies in Beh\u00e7et's disease","volume":"17","author":"R Bergman","year":"1990","journal-title":"J Dermatol"},{"key":"pone.0227836.ref035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0049-3848(97)00299-5","article-title":"Anticardiolipin antibodies in clinical conditions associated with a risk of thrombotic events","volume":"89","author":"J.R Hughes","year":"1998","journal-title":"Thromb Res"},{"key":"pone.0227836.ref036","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00296-001-0157-8","article-title":"Clinical features of Beh\u00e7et's disease in patients in the Sultanate of Oman; the significance of antiphospholipid antibodies?","volume":"21","author":"E El-Ageb","year":"2002","journal-title":"Rheumatol Int"},{"key":"pone.0227836.ref037","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9343(01)01048-8","article-title":"Vascular involvement in Beh\u00e7et\u2019s disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin","volume":"112","author":"G Espinosa","year":"2002","journal-title":"Am J Med"},{"key":"pone.0227836.ref038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5021\/ad.1992.4.1.1","article-title":"Anticardiolipin antibodies in patients with Beh\u00e7et's disease","volume":"4","author":"H.G Ji","year":"1992","journal-title":"Ann Dermatol"},{"key":"pone.0227836.ref039","doi-asserted-by":"crossref","first-page":"58","DOI":"10.17305\/bjbms.2011.2625","article-title":"Anticardiolipin antibodies in patients with Behcet\u2019s disease","volume":"11","author":"M Zivkovic","year":"2011","journal-title":"Bosn J Basic Med Sci"},{"key":"pone.0227836.ref040","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.2174\/1381612822666160527160029","article-title":"Antiphospholipid antibody-mediated thrombotic mechanisms in antiphospholipid syndrome: towards pathophysiology-based treatment","volume":"22","author":"M.A Islam","year":"2016","journal-title":"Curr Pharm Des"},{"key":"pone.0227836.ref041","first-page":"PA3129","article-title":"Clinical characteristics and outcome of patients with Beh\u00e7et\u2019s Disease and thrombosis","author":"S Erol","year":"2018","journal-title":"Eur Respir J 52"},{"key":"pone.0227836.ref042","first-page":"748","article-title":"Comparison of clinical features of Behcet disease according to age in a Tunisian cohort","volume":"52","author":"A Hamzaoui","year":"2014","journal-title":"Acta Med Iran"},{"key":"pone.0227836.ref043","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/ard.43.5.746","article-title":"Anticardiolipin antibodies: occurrence in Beh\u00e7et's syndrome","volume":"43","author":"R Hull","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"pone.0227836.ref044","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0038-1646409","article-title":"Coagulation and fibrinolytic activity in Behcet's disease","volume":"66","author":"K Hampton","year":"1991","journal-title":"Thromb Haemost"},{"key":"pone.0227836.ref045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0609.1996.tb00499.x","article-title":"Haemostatic markers of procoagulant imbalance in Behcet's disease","volume":"57","author":"I.C Haznedaro\u01e7lu","year":"1996","journal-title":"Eur J Haematol"},{"key":"pone.0227836.ref046","article-title":"Arterial aneurysms in Beh\u00e7et\u2019s disease patients: Frequency, clinical characteristics and long-term outcome","volume":"1","author":"N El-Ghobashy","year":"2018","journal-title":"Egypt Rheumatol"},{"key":"pone.0227836.ref047","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/24725625.2017.1398303","article-title":"Concurrent pulmonary artery aneurysms and intracardiac thrombus in a Caucasian man with Beh\u00e7et\u2019s disease: case report and literature review","volume":"2","author":"J Liew","year":"2018","journal-title":"Mod Rheumatol Case Rep"},{"key":"pone.0227836.ref048","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/00004728-200207000-00023","article-title":"Pulmonary arterial aneurysms in primary antiphospholipid antibody syndrome","volume":"26","author":"M.H Chung","year":"2002","journal-title":"J Comput Assist Tomogr"},{"key":"pone.0227836.ref049","doi-asserted-by":"crossref","first-page":"e99302","DOI":"10.1371\/journal.pone.0099302","article-title":"Antiphospholipid antibodies predict progression of abdominal aortic aneurysms","volume":"9","author":"C Duftner","year":"2014","journal-title":"PLoS One"},{"key":"pone.0227836.ref050","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2174\/1871527315666160920122750","article-title":"\u2018Non-criteria\u2019neurologic manifestations of antiphospholipid syndrome: a hidden kingdom to be discovered","volume":"15","author":"A.M Islam","year":"2016","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"pone.0227836.ref051","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/0333102417694881","article-title":"Coexistence of antiphospholipid antibodies and cephalalgia","volume":"38","author":"M.A Islam","year":"2018","journal-title":"Cephalalgia"},{"key":"pone.0227836.ref052","first-page":"65","article-title":"Infliximab treatment-induced formation of autoantibodies is common in Beh\u00e7et's disease","volume":"25","author":"A Elezoglou","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"pone.0227836.ref053","article-title":"Auto-immunity profile evaluation during different clinical manifestations of Beh\u00e7et disease in Algerian patients: effect of corticosteroid treatment","author":"F Djaballah-Ider","journal-title":"Inflammopharmacology"},{"key":"pone.0227836.ref054","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"S Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"pone.0227836.ref055","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/jth.13976","article-title":"Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH","volume":"16","author":"K Devreese","year":"2018","journal-title":"J Thromb Haemost"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T01:48:08Z","timestamp":1665452888000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227836"}},"subtitle":[],"editor":[{"given":"Ghulam Md","family":"Ashraf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,13]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0227836","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,13]]}}}